Nf1 gene targeting: Toward models and mechanisms

Seminars in Cancer Biology

Volumn 7, Issue 5, 1996, Pages 291-298

  Cichowski, Karen ^a   Shih, T Shane ^a   Jacks, Tyler ^a  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

Myeloid leukemia; Neurofibroma; NF1; Targeted disruption; Tumor suppressor

Indexed keywords

ANIMAL MODEL; CANCER GENETICS; CANCER SUSCEPTIBILITY; CHIMERA; GENE DISRUPTION; GENE TARGETING; MODEL; MOUSE; NERVE SHEATH TUMOR; NEUROFIBROMATOSIS; NONHUMAN; REVIEW; SEQUENCE HOMOLOGY;

EID: 0030265476     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1006/scbi.1996.0037     Document Type: Review

References (52)

1. 1. Stumph DA (1987) Arch Neurol 45:575-578
2. 2. Riccardi VM (1992) Neurofibromatosis: Phenotype, Natural History, and Pathogenesis. John Hopkins Press, Baltimore and London
3. 3. Bader JL (1986) Neurofibromatosis and cancer. Ann NY Acad Sci 486:57-65
4. 4. Hope DG, Mulvihill JJ (1981) Malignancy in neurofibromatosis. Adv Neurol 29:33-56
5. 5. Cawthon RM et al (1990) A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations. Cell 62:193-201
6. 6. Viskochil D et al (1990) Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus. Cell 62:187-192
7. 7. Wallace MR et al (1990) Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. Science 249:181-186
8. 8. Xu GF et al (1990) The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 62:599-608
9. 9. Ballester R et al (1990) The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins. Cell 63:851-859
10. 10. Martin GA et al (1990) The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21. Cell 63:843-849
11. 11. Xu GF et al (1990) The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements ira mutants of S. cerevisiae. Cell 63:835-841
12. 12. Basu TN et al (1992) Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients. Nature 356:713-715
13. 13. DeClue JE et al (1992) Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis. Cell 69:265-273
14. 14. Guha A et al (1996) Ras-GTP levels are elevated in human NF1 peripheral nerve tumors. Oncogene 12:507-513
15. 15. Bollag G et al (1996) Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells. Nature Genet 12:144-148
16. 16. Ponder B (1990) Human genetics. Neurofibromatosis gene cloned. Nature 346:703-704
17. 17. Seizinger BR (1993) NF1: a prevalent cause of tumorigenesis in human cancers? Nat Genet 3:97-99
18. 18. Shannon KM et al (1994) Loss of the normal NF1 allele from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disorders. N Engl J Med 330:597-601
19. 19. Legius E, Marchuk DA, Collins FS, Glover TW (1993) Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis. Nat Genet 3:122-126
20. 20. Colman SD, Williams CA, Wallace MR (1995) Benign neurofibromas in type 1 neurofibromatosis (NF1) show somatic deletions of the NF1 gene. Nat Genet 11:90-92
21. 21. Xu W et al (1992) Loss of NF1 alleles in phaeochromocytomas from patients with type I neurofibromatosis. Genes Chromosom Cancer 4:337-342
22. 22. Jacks T et al (1994) Tumour predisposition in mice heterozygous for a targeted mutation in NF1. Nat Genet 7:353-361
23. 23. Brannan CI et al (1994) Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues. Genes Dev 8:1019-1029
24. 24. Kirby ML, Gale TF, Stewart DE (1983) Neural crest cells contribute to normal aorticopulmonary septation, Science 220:1059-1061
25. 25. Largaespada DA, Brannan CI, Jenkins NA & Copeland NG (1996) Nf1 deficiency causes Ras-mediated granulocyte/ macrophage colony stimulating factor hypersensitivity and chronic myeloid leukaemia. Nature Genet 12:137-143
26. 26. Emanuel PD, Bates LJ, Castleberry RP, Gualtieri RJ, Zuckerman KS (1991) Selective hypersensitivity to granulocyte-macrophage colony-stimulating factor by juvenile chronic myeloid leukemia hematopoietic progenitors. Blood 77:925-929
27. 27. Satoh T, Nakafuku M, Miyajima A, Kaziro Y (1991) Involvement of ras p21 protein in signal-transduction pathways from interleukin 2, interleukin 3, and granulocyte/ macrophage colony-stimulating factor, but not from interleukin 4. Proc Natl Acad Sci USA 88:3314-3318
28. 28. Largaespada DA, Brannan CI, Shaughnessy JD, Jenkins NA, Copeland NG (1996) The neurofibromatosis type 1 (NF1) tumor suppressor gene and myeloid leukemia. Curr Top Microbiol Immunol 211:233-239
29. 29. Kalra R, Paderanga DC, Olson K, Shannon KM (1994) Genetic analysis is consistent with the hypothesis that NF1 limits myeloid cell growth through p21ras. Blood 84:3435-3439
30. 30. Bedigian HG, Johnson DA, Jenkins NA, Copeland NG, Evans R (1984) Spontaneous and induced leukemias of myeloid origin in recombinant inbred BXH mice. J Virol 51:586-594
31. 31. Buchberg AM, Bedigian HG, Jenkins NA, Copeland NG (1990) Evi-2, a common integration site involved in murine myeloid leukemogenesis. Mol Cell Biol 10:4658-4666
32. 32. Sawada S et al (1996) Identification of NF1 mutations in both alleles of a dermal neurofibroma. Nature Genet 14:110-112
33. 33. Sheela S, Riccardi VM, Ratner N (1990) Angiogenic and invasive properties of neurofibroma Schwann cells. J Cell Biol 111:645-653
34. 34. Stefannson K, Wollmann R, Jerkovic M (1982) S-100 protein in soft tissue tumors derived from Schwann cells and melanocytes. Am J Pathol 106:261-268
35. 35. Kim HA, Rosenbaum T, Marchionni MA, Ratner N, DeClue JE (1995) Schwann cells from neurofibromin deficient mice exhibit activation of p21 ras, inhibition of cell proliferation and morphological changes. Oncogene 11:325-335
36. 36. Carraway KL, Cantley LC (1994) A new acquaintance for erbB3 and erbB4: a role for receptor heterodimerization in growth signaling. Cell 78:5-8
37. 37. Muroya K, Hattori S, Nakamura S (1992) Nerve growth factor induces rapid accumulation of the GTP-bound form of p21ras in rat pheochromocytoma PC12 cells. Oncogene 7:277-281
38. 38. Bar-Sagi D, Feramisco JR (1985) Microinjection of the ras oncogene protein into PC12 cells induces morphological differentiation. Cell 42:841-848
39. 39. Ridley AJ, Paterson HF, Noble M, Land H (1988) Ras-mediated cell cycle arrest is altered by nuclear oncogen es to induce Schwann cell transformation. Embo J 7:1635-1645
40. 40. Menon AG et al (1990) Chromosome 17p deletions and p53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis. Proc Natl Acad Sci USA 87:5435-5439
41. 41. Wiestler OD, Radner H (1994) in The Neurofibromatoses (Huson SM, Hughes RAC, eds) pp 135-159. Chapman and Hall, London
42. 42. Upadhyaya M et al (1995) Characterisation of germline mutations in the neurofibromatosis type 1 (NF1) gene. J Med Genet 32:706-710
43. 43. Rosenbaum T et al (1995) Neurofibromin-deficient fibroblasts fail to form perineurium in vitro. Development 121:3583-3592
44. 44. Thomas PK, Olsson Y (1984) in Peripheral Neuropathy (Dyck PJ, Thomas PK, Lambert EH, Bunge RP, eds) pp 97-120. W.B. Saunders, Philadelphia
45. 45. Bunge MB, Wood PM, Tynan LB, Bates ML, Sanes JR (1989) Perineurium originates from fibroblasts: demonstration in vitro with a retroviral marker. Science 243:229-231
46. 46. Vogel KS, Brannan CI, Jenkins NA, Copeland NG, Parada LF (1995) Loss of neurofibromin results in neurotrophin-independent survival of embryonic sensory and sympathetic neurons. Cell 82:733-742
47. 47. Oppenheim RW (1991) Cell death during development of the nervous system. Annu Rev Neurosci 14:453-501
48. 48. Greenblatt MS, Bennett WP, Hollstein M, Harris CC (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54:4855-4878
49. 49. Williams BO et al (1994) Cooperative tumorigenic effects of germline mutations in Rb and p53. Nature Genet 7:480-484
50. 50. Purdie CA et al (1994) Tumour incidence, spectrum and ploidy in mice with a large deletion in the p53 gene. Oncogene 9:603-609
51. 51. Jacks T et al (1994) Tumor spectrum analysis in p53-mutant mice. Curr Biol 4:1-7
52. 52. Donehower LA et al (1992) Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356:215-221